Daily non-political popular news in brief.

Study Reveals Mechanism For Cancer-drug Resistance

10-11-2006 · ScienceDaily

Using the worm Caenorhabditis elegans, researchers at UT Southwestern Medical Center have discovered a mechanism by which cancer cells become resistant to a specific class of drugs.

Keywords: study, reveals, mechanism, cancer-drug, resistance, reveal, cancer, drug

« Previous | Next »

Similar news on "Study Reveals Mechanism For Cancer-drug Resistance":

Study reveals aspirin's colorectal cancer prevention mechanism
05-23-2007 · EurekAlert!
Aspirin therapy's ability to reduce the risk of colorectal cancer, seen in a large number of studies, appears to depend on the drug's inhibition of the COX-2 enzyme, the action that also underlies aspirin's usefulness for treating pain and inflammation. Investigators from Massachusetts General Hospital, Dana-Farber Cancer Institute and Brigham and Women’s Hospital have found that regular aspirin intake only reduced the incidence of colorectal tumors that overexpress COX-2.
Similar news · Read more »
Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy
02-10-2008 · EurekAlert!
A team of researchers led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin.
Similar news · Read more »
Other highlights in the Sept. 25 JNCI
09-25-2007 · EurekAlert!
Also in the Sept. 25 JNCI are a study on accuracy in prostate cancer diagnosis, a commentary about redefining cancer stem cells, a review of how the tumor microenvironment plays a role in drug resistance and an alternative phase II trial design.
Similar news · Read more »
Unstable leukemia stem cells may predispose patients to drug resistance
05-01-2007 · EurekAlert!
The BCR-ABL gene in chronic myeloid leukemia stem cells has a tendency to quickly mutate, and this may help explain why patients are predisposed to resistance to drugs like imatinib that target that gene, according to a study in the May 2 Journal of the National Cancer Institute.
Similar news · Read more »
Neural stem cell study reveals mechanism that may play role in cancer
09-04-2007 · EurekAlert!
In the dynamic world of the developing brain, neural stem cells give rise to neurons deep within the brain’s fluid-filled ventricles. These newborn neurons then migrate along the stem cell fibers up to the neocortex, the seat of higher cognitive functions. Now, scientists have discovered a key mechanism of this migration -- one that may also play an important role in other developmental processes and diseases, including cancer.
Similar news · Read more »
Drug that interrupts a key stage of cell division shows promise for advanced solid tumors
11-08-2006 · EurekAlert!
One of the first studies to investigate the effects of a new anti-cancer drug in patients with advanced or metastatic solid tumours has shown that it is capable of halting progression of the disease, and the study has provided the first proof of the drug's mechanism of action, the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Prague was told on Wednesday.
Similar news · Read more »
Drug industry increasingly influences breast cancer research
02-26-2007 · EurekAlert!
Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Similar news · Read more »
'Wrapping' Gleevec fights drug-resistant cancer
05-01-2007 · EurekAlert!
A study in this week's Cancer Research finds the anti-cancer drug Gleevec is far more effective against a drug-resistant strain of cancer when it wraps the target with a molecular bandage that seals out water from a critical area. The wrapping version of the drug -- known as WBZ-7 -- was created, produced and tested by three research teams from Rice University and the University of Texas M. D. Anderson Cancer Center in Houston.
Similar news · Read more »
Nanoparticles hitchhike on red blood cells: a potential new method for drug delivery
06-27-2007 · EurekAlert!
Polymeric nanoparticles are excellent carriers for delivering drugs. However, they are quickly removed from the blood, sometimes in minutes, rendering them ineffective in delivering drugs. This study reports that nanoparticles can be forced to remain in circulation by attaching to red blood cells. Prolonged circulation of nanoparticles in the blood may potentially open new opportunities for the treatment of conditions such as cancer and heart disease.
Similar news · Read more »
New weapon to fight leukemia
08-23-2007 · EurekAlert!
A new study indicates that the drug FTY720 prevents disease in a mouse model of two leukemias -- blast crisis chronic myeloid leukemia and acute lymphocytic leukemia -- caused by the cancer protein BCR-ABL. As the drug also induced cell lines from humans with these leukemias to die in vitro the authors suggest that FTY720 should be considered by researchers and clinicians developing new approaches to treat CML-BC and ALL.
Similar news · Read more »